Share This Page
Drug Price Trends for NDC 66758-0237
✉ Email this page to a colleague
Average Pharmacy Cost for 66758-0237
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FOCALIN XR 15 MG CAPSULE | 66758-0237-01 | 4.91168 | EACH | 2025-03-19 |
| FOCALIN XR 15 MG CAPSULE | 66758-0237-01 | 4.91040 | EACH | 2025-02-19 |
| FOCALIN XR 15 MG CAPSULE | 66758-0237-01 | 4.91360 | EACH | 2024-12-04 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 66758-0237
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| No data available in table | |||||||
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 66758-0238
Understanding the NDC Directory
To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is essential to understand the FDA's National Drug Code Directory. This directory contains comprehensive information on finished, unfinished, and compounded drug products, including their NDC numbers, product types, non-proprietary names, dosage forms, routes of administration, and marketing dates[1][5].
Identifying the Drug
The NDC 66758-0238 is a unique identifier for a specific drug product. To proceed with the analysis, one must first identify the drug associated with this NDC.
Search the NDC Directory
Use the FDA's NDC Directory to find the proprietary name, non-proprietary name, dosage form, route of administration, and labeler name of the drug. This step is crucial for gathering all relevant details about the drug[1][5].
Market Analysis
Market Trends
The pharmaceutical market is undergoing significant transformations driven by technological advancements, regulatory shifts, and evolving patient needs.
- Technological Advancements: AI and gene editing are accelerating drug development, reducing costs, and speeding up the time from lab to market. By 2025, AI is expected to be a key partner in research labs, enhancing efficiency and accuracy in drug development[1].
- Immunotherapies and Targeted Therapies: In markets like Non-Small Cell Lung Cancer (NSCLC), immunotherapies and targeted therapies are driving growth. Drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025[4].
Competitive Landscape
Understanding the competitive landscape is vital for analyzing the market for a specific drug.
- Competitor Drugs: Identify other drugs in the same therapeutic class and their market performance. For instance, in the NSCLC market, Keytruda, Opdivo, and Tecentriq are major competitors[4].
- Generic and Biosimilar Impact: The entry of generic or biosimilar versions can significantly impact the market share and pricing of branded drugs. For example, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales[4].
Price Projections
Pricing Factors
Several factors influence the pricing of pharmaceuticals:
- Regulatory Environment: Changes in regulatory policies can affect drug pricing. Stricter rules about patient data and drug safety may impact pricing strategies[1].
- Market Demand: The demand for a drug, driven by its efficacy, safety profile, and patient needs, plays a crucial role in pricing.
- Competition: The presence of competitor drugs, especially generics or biosimilars, can drive prices down.
- Economic Conditions: Economic factors such as inflation, healthcare policies, and reimbursement rates can also influence drug prices[1].
Example Pricing Analysis
In the NSCLC market, the prices of immunotherapies and targeted therapies are expected to remain high due to their efficacy and the lack of significant generic competition until 2025.
- Keytruda: Projected to contribute $5.2 billion in sales by 2025, with a moderate CAGR[4].
- Generic Impact: The sales of generic versions of drugs like erlotinib and pemetrexed are expected to grow but will not significantly impact the overall market size until 2025[4].
Specific Drug Analysis
General Approach
Without the specific details of the drug associated with NDC 66758-0238, here is a general approach to analyzing its market and price projections:
- Identify the Drug: Use the NDC Directory to find the proprietary name, non-proprietary name, and other relevant details.
- Market Research: Conduct market research to understand the competitive landscape, patient demand, and regulatory environment.
- Pricing Trends: Analyze pricing trends for similar drugs in the same therapeutic class.
- Forecasting: Use historical data and market trends to forecast future prices, considering factors like competition, regulatory changes, and economic conditions[1].
Impact of Technological Advancements
AI and Data Integration
The integration of technologies like AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations in the pharmaceutical industry. By 2025, AI is likely to be an essential tool in research labs, enhancing the efficiency and accuracy of drug development[1][3].
Competitive Pressures
Generic and Biosimilar Competition
The entry of generic or biosimilar versions of drugs can significantly impact the market share and pricing of branded drugs. For example, the patent expiration of Tarceva and Alimta has led to a decline in their sales and an increase in generic sales. By 2025, biosimilar versions of high-revenue drugs are expected to capture a significant market share, driving down prices of branded drugs[3][4].
Regulatory and Economic Factors
Regulatory Environment
Changes in regulatory policies can affect drug pricing. Stricter rules about patient data and drug safety may impact pricing strategies. Additionally, regulatory shifts can influence the approval and marketing of new drugs, affecting their market entry and pricing[1].
Economic Conditions
Economic factors such as inflation, healthcare policies, and reimbursement rates can also influence drug prices. For instance, changes in healthcare policies can affect the reimbursement rates for certain drugs, impacting their market demand and pricing[1].
Life Sciences Industry Outlook
Optimism and Challenges
The life sciences industry is poised for significant transformation in 2025, driven by digital advancements and scientific innovations. Despite competitive pressures and business volatility, most global life sciences executives are optimistic about the future. However, pricing and access to drugs remain significant issues, with nearly half of executives expecting these factors to significantly affect their strategies in 2025[3].
Unmet Needs and Emerging Therapies
Immunotherapies and Targeted Therapies
In specific markets like NSCLC, immunotherapies and targeted therapies are addressing unmet needs and driving market growth. Drugs like Keytruda, Opdivo, and Tecentriq are projected to achieve blockbuster status by 2025, with sales collectively reaching $17.5 billion[4].
GLP-1 Market
The GLP-1 market is another area of significant growth, with these drugs being evaluated for a wide range of common conditions including obesity, sleep apnea, addiction, Alzheimer’s disease, nonalcoholic fatty liver disease, and steatohepatitis. The effectiveness of GLP-1s in treating obesity and related conditions is expected to reduce the demand for medical devices and surgical procedures related to diabetes and obesity[3].
Key Takeaways
- NDC Directory: A crucial resource for identifying and analyzing drug products.
- Market Trends: Technological advancements, regulatory shifts, and evolving patient needs are reshaping the pharmaceutical market.
- Competitive Landscape: Understanding competitor drugs and their market performance is essential for pricing strategies.
- Pricing Factors: Regulatory environment, market demand, competition, and economic conditions all influence drug pricing.
- Technological Integration: AI and data integration are expected to enhance operational efficiencies and drive innovations.
- Regulatory and Economic Factors: Changes in regulatory policies and economic conditions can significantly impact drug pricing and market demand.
FAQs
Q: What is the NDC Directory and how is it used? A: The NDC Directory is a resource provided by the FDA that contains comprehensive information on drug products, including their NDC numbers, product types, and other relevant details. It is used to identify and analyze drug products.
Q: How do technological advancements impact drug development and pricing? A: Technological advancements, such as AI and gene editing, are accelerating drug development, reducing costs, and speeding up the time from lab to market. These advancements can also influence pricing by enhancing efficiency and accuracy in drug development.
Q: What is the impact of generic and biosimilar drugs on the market? A: The entry of generic or biosimilar versions of drugs can significantly reduce the market share and pricing of branded drugs. This is evident in the decline of sales for drugs like Tarceva and Alimta following the introduction of their generic versions.
Q: How do regulatory changes affect drug pricing? A: Changes in regulatory policies can affect drug pricing by influencing the approval and marketing of new drugs, as well as impacting pricing strategies related to patient data and drug safety.
Q: What are some emerging trends in the life sciences industry for 2025? A: The life sciences industry is expected to see significant transformation driven by digital advancements, scientific innovations, and the integration of AI and data. Emerging trends include the growth of the GLP-1 market and the increasing importance of personalized medicine.
Sources
- DrugPatentWatch - Market Analysis and Price Projections for the Drug NDC: 66758-0238.
- DrugPatentWatch - Latest drug prices and trends for NDC 51672-1387.
- Deloitte Insights - 2025 life sciences outlook.
- Drug Development - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025.
- YouTube - NDC Directory (March 2015).
More… ↓
